Contract RP/RPi
We offer experienced contract RPs for all types of WDA(H) holders in the UK. Our service includes an initial review of your business to assess the necessary level of RP involvement to ensure compliance with GDP and regulatory requirements.

1
Contract Responsible Person (RP)
We provide Contract Responsible Person (RP) services to support UK-based companies holding a Wholesale Distribution Authorisation (WDAh) for medicinal products. In line with Good Distribution Practice (GDP) and UK Human Medicines Regulations 2012, we act as your named RP, ensuring full regulatory compliance across your supply chain.
​
Our RP services include:
-
Oversight of GDP-compliant quality sytems
-
Verification of suppliers and customers' authorisations
-
Training management and oversight- Site specific GDP/QMS training
-
Preparation and involvment during quality management review meetings
-
Monitoring and approval of temperature-controlled storage and transport
-
Management of recalls and complaints
-
Approval of SOPs and training programmes
-
Performing self-inspections at appropriate regular intervals following a prearranged programme.
-
Decision process for the final disposition of returned, rejected, recalled or falsified products.
-
Preparation and support for MHRA inspections
By partnering with us, you gain a compliant and experienced RP without the cost of a full-time internal resource.
2
Responsible Person Import (RPi) Services
For medicinal products imported into Great Britain from the European Economic Area (EEA), we offer expert Responsible Person import (RPi) services following UK post-Brexit requirements.
​
As your designated RPi, we ensure:
-
Verification that each imported batch has been released by a Qualified Person(QP) in an approved country
-
Maintenance of full batch documentation for inspection purposes
-
Compliance with GDP for all import activities
-
Direct liaison with the MHRA on import-related matters
​​
We provide a UK-based solution for importers needing a compliant RPi to legally place EEA-certified medicines on the GB market.
